SCHEMBL8508575

SCHEMBL8508575

COCCOc1c(O)c(CCN)c2ccccc2c1Br

nearest known ligand 0.34

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 1/20 0.32
▸ HTR6 P50406 1/20 0.32
▸ MPO P05164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6824162 0.83 TSHR (0.35) TSHRHTR6
SCHEMBL6824618 0.70 NR1H4 (0.36) TSHR
SCHEMBL5397834 0.67 ALDH1A1 (0.50) TSHRMPO
SCHEMBL29502702 0.67 ALDH1A1 (0.50) TSHRMPO
SCHEMBL6824158 0.65 DRD3 (0.52) —
SCHEMBL29937263 0.65 PTPN1 (0.33) —
SCHEMBL23271976 0.63 SMN1; SMN2 (0.44) TSHRMPO
SCHEMBL30003031 0.63 SMN1; SMN2 (0.44) TSHRMPO
SCHEMBL7875810 0.63 MPO (0.45) TSHRMPO
SCHEMBL19616950 0.61 KDM4E (0.43) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999032112-A1 METHOD FOR TREATING DIABETES ELI LILLY AND COMPANY (US) 1999-07-01 — — WO disclosed
Send feedback